PubRank

Marin H Kollef

Author PubWeight™ 284.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 2012 7.97
2 Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002 6.13
3 Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003 5.64
4 Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005 5.35
5 Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest 2006 4.51
6 Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med 2006 4.10
7 Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002 3.98
8 Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008 3.88
9 Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 2011 3.78
10 The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 2007 3.63
11 Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 2005 3.49
12 Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clin Infect Dis 2011 3.20
13 Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008 3.13
14 Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA 2012 3.13
15 The importance of fluid management in acute lung injury secondary to septic shock. Chest 2009 2.92
16 Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy. Crit Care Med 2015 2.87
17 Time to Appropriate Antibiotic Therapy Is an Independent Determinant of Postinfection ICU and Hospital Lengths of Stay in Patients With Sepsis. Crit Care Med 2015 2.86
18 Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med 2005 2.70
19 Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003 2.59
20 Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest 2008 2.57
21 Hospital-wide impact of a standardized order set for the management of bacteremic severe sepsis. Crit Care Med 2009 2.57
22 Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database. Crit Care Med 2006 2.51
23 Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007 2.49
24 Implementation of a real-time computerized sepsis alert in nonintensive care unit patients. Crit Care Med 2011 2.35
25 Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis. Chest 2013 2.32
26 A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004 2.26
27 Endotracheal tube intraluminal volume loss among mechanically ventilated patients. Crit Care Med 2004 2.20
28 Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med 2011 2.16
29 Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010 2.15
30 Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr 2002 2.15
31 Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2004 2.13
32 Pneumonia Pathogen Characterization Is an Independent Determinant of Hospital Readmission. Chest 2015 2.09
33 Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. Chest 2009 2.09
34 Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit Care Med 2008 2.06
35 A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther 2007 2.05
36 Attitudes of respiratory therapists and nurses about measures to prevent ventilator-associated pneumonia: a multicenter, cross-sectional survey study. Respir Care 2007 2.03
37 Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patients. Crit Care Med 2005 1.92
38 Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Crit Care Med 2007 1.88
39 Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment. Crit Care Med 2006 1.86
40 A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria. Crit Care Med 2012 1.82
41 Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2008 1.81
42 Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy. Crit Care Med 2006 1.80
43 Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 2002 1.72
44 Inappropriate therapy for methicillin-resistant Staphylococcus aureus: resource utilization and cost implications. Crit Care Med 2008 1.72
45 Antimicrobial stewardship in the intensive care unit: advances and obstacles. Am J Respir Crit Care Med 2009 1.71
46 Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest 2002 1.63
47 Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia. Respir Care 2012 1.62
48 Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol 2007 1.61
49 Nursing adherence with evidence-based guidelines for preventing ventilator-associated pneumonia. Crit Care Med 2003 1.61
50 Identifying critically ill patients at risk for inappropriate antibiotic therapy: a pilot study of a point-of-care decision support alert. Crit Care Med 2014 1.60
51 Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals. Clin Infect Dis 2013 1.60
52 A prospective evaluation of ventilator-associated conditions and infection-related ventilator-associated conditions. Chest 2015 1.59
53 Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med 2008 1.58
54 Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: frequency, outcomes, and risk factors. Crit Care Med 2006 1.57
55 Use of a handheld computer by respiratory care practitioners to improve the efficiency of weaning patients from mechanical ventilation. Crit Care Med 2002 1.56
56 The modified APACHE II score outperforms Curb65 pneumonia severity score as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus pneumonia. Chest 2007 1.53
57 A randomized trial of conventional chest physical therapy versus high frequency chest wall compressions in intubated and non-intubated adults. Respir Care 2011 1.51
58 Patient safety event reporting in critical care: a study of three intensive care units. Crit Care Med 2007 1.51
59 Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin. Crit Care Med 2004 1.49
60 Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest 2008 1.47
61 Non-invasive stroke volume measurement and passive leg raising predict volume responsiveness in medical ICU patients: an observational cohort study. Crit Care 2009 1.47
62 Epidemiology and outcomes of clostridium difficile-associated disease among patients on prolonged acute mechanical ventilation. Chest 2009 1.47
63 Physicians' estimates of cardiac index and intravascular volume based on clinical assessment versus transesophageal Doppler measurements obtained by critical care nurses. Am J Crit Care 2003 1.46
64 Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest 2004 1.45
65 Diagnostic utility of plasma procalcitonin for nosocomial pneumonia in the intensive care unit setting. Respir Care 2011 1.45
66 Prevention of hospital infection. Microbes Infect 2005 1.45
67 Ambulatory care-sensitive conditions: clinical outcomes and impact on intensive care unit resource use. South Med J 2003 1.42
68 Secular trends in candidemia-related hospitalization in the United States, 2000-2005. Infect Control Hosp Epidemiol 2008 1.42
69 Activity of a silver-coated endotracheal tube in preclinical models of ventilator-associated pneumonia and a study after extubation. Crit Care Med 2010 1.42
70 Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial. Clin Infect Dis 2005 1.40
71 Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study. Surg Infect (Larchmt) 2007 1.39
72 Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care 2006 1.37
73 Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin resistance matter? Infect Control Hosp Epidemiol 2010 1.34
74 Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials. Crit Care 2010 1.33
75 Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther 2003 1.33
76 Analysis of 30-day mortality for clostridium difficile-associated disease in the ICU setting. Chest 2007 1.30
77 Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis 2010 1.29
78 Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother 2010 1.27
79 Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy 2010 1.25
80 Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis. Crit Care Med 2002 1.25
81 The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 2004 1.24
82 Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000-2005. Pediatr Infect Dis J 2008 1.20
83 Transfusion practice and blood stream infections in critically ill patients. Chest 2005 1.19
84 Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia?: a survey based on the opinions of an international panel of intensivists. Chest 2002 1.18
85 A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia. Crit Care 2012 1.18
86 An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. Chest 2004 1.16
87 Red blood cell transfusion and ventilator-associated pneumonia: A potential link? Crit Care Med 2004 1.15
88 Fluid balance and cardiac function in septic shock as predictors of hospital mortality. Crit Care 2013 1.14
89 Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2005 1.13
90 Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 2004 1.13
91 Reporting of medical errors: an intensive care unit experience. Crit Care Med 2004 1.13
92 Early prediction of septic shock in hospitalized patients. J Hosp Med 2010 1.12
93 Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005. Emerg Infect Dis 2008 1.10
94 Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations. Chest 2007 1.09
95 Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients. Crit Care Med 2004 1.09
96 A comparison of culture-positive and culture-negative health-care-associated pneumonia. Chest 2009 1.07
97 A trial of a real-time alert for clinical deterioration in patients hospitalized on general medical wards. J Hosp Med 2013 1.06
98 Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 2005 1.06
99 Economic burden of ventilator-associated pneumonia based on total resource utilization. Infect Control Hosp Epidemiol 2010 1.05
100 Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia. Crit Care Med 2007 1.05
101 The epidemiology of vancomycin-resistant Enterococcus colonization in a medical intensive care unit. Infect Control Hosp Epidemiol 2003 1.04
102 Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia. J Hosp Med 2011 1.04
103 A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. BMC Infect Dis 2013 1.03
104 Daily bathing with chlorhexidine-based soap and the prevention of Staphylococcus aureus transmission and infection. Infect Control Hosp Epidemiol 2014 1.02
105 The importance of appropriate initial antibiotic therapy for hospital-acquired infections. Am J Med 2003 1.02
106 Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med 2009 1.01
107 Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment. Crit Care Med 2010 1.00
108 The importance of early treatment with doxycycline in human ehrlichiosis. Medicine (Baltimore) 2008 0.99
109 Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes. J Hosp Med 2010 0.99
110 Optimizing antibiotic treatment for ventilator-associated pneumonia. Pharmacotherapy 2006 0.99
111 Predictors of hospital mortality for patients with severe sepsis treated with Drotrecogin alfa (activated). Pharmacotherapy 2005 0.98
112 Timing of Appropriate Antibiotics in Sepsis: How Much Does Each Hour Matter? Crit Care Med 2016 0.98
113 The management of severe sepsis and septic shock. Infect Dis Clin North Am 2009 0.97
114 Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors. Infect Control Hosp Epidemiol 2009 0.96
115 Predicting bacteremia among patients hospitalized for skin and skin-structure infections: derivation and validation of a risk score. Infect Control Hosp Epidemiol 2010 0.96
116 Candidemia on presentation to the hospital: development and validation of a risk score. Crit Care 2009 0.95
117 Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit Care Med 2009 0.95
118 Early and adequate antibiotic therapy in the treatment of severe sepsis and septic shock. Curr Infect Dis Rep 2011 0.94
119 Health care-associated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcome. Medicine (Baltimore) 2011 0.93
120 Probiotics for preventing ventilator-associated pneumonia. Cochrane Database Syst Rev 2014 0.93
121 Mechanical Ventilation and ARDS in the ED: A Multicenter, Observational, Prospective, Cross-sectional Study. Chest 2015 0.93
122 Health care-associated pneumonia: identification and initial management in the ED. Am J Emerg Med 2008 0.92
123 Clostridium difficile infection: a multicenter study of epidemiology and outcomes in mechanically ventilated patients. Crit Care Med 2013 0.91
124 Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia. Int J Infect Dis 2011 0.91
125 Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study. Ann Pharmacother 2013 0.91
126 Antibiotic stewardship in the intensive care unit. Semin Respir Crit Care Med 2011 0.89
127 Diagnosis of ventilator-associated pneumonia. N Engl J Med 2006 0.89
128 The influence of infection on hospital mortality for patients requiring > 48 h of intensive care. Chest 2003 0.89
129 Ventilator-associated pneumonia in a multi-hospital system: differences in microbiology by location. Infect Control Hosp Epidemiol 2003 0.89
130 Recognition and prevention of nosocomial pneumonia in the intensive care unit and infection control in mechanical ventilation. Crit Care Med 2010 0.88
131 Clinical utility of blood cultures drawn from central vein catheters and peripheral venipuncture in critically ill medical patients. Chest 2003 0.87
132 Providing appropriate antimicrobial therapy in the intensive care unit: surveillance vs. de-escalation. Crit Care Med 2006 0.87
133 An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis. BMC Infect Dis 2012 0.87
134 Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit. Crit Care 2009 0.87
135 Occurrence and predictors of dexmedetomidine infusion intolerance and failure. Hosp Pract (1995) 2012 0.86
136 Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study. BMC Infect Dis 2014 0.86
137 Antimicrobial stewardship programs: mandatory for all ICUs. Crit Care 2012 0.86
138 Ventilator associated pneumonia in the ICU: where has it gone? Curr Opin Pulm Med 2015 0.86
139 Increasing incidence of sterile-site infections due to non-multidrug-resistant, oxacillin-resistant Staphylococcus aureus among hospitalized patients. Infect Control Hosp Epidemiol 2006 0.85
140 Ventilator-associated pneumonia: insights from recent clinical trials. Chest 2005 0.85
141 The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis. Chest 2015 0.84
142 The alphabet soup of pneumonia: CAP, HAP, HCAP, NHAP, and VAP. Semin Respir Crit Care Med 2009 0.84
143 Reducing the burden of acute respiratory distress syndrome: the case for early intervention and the potential role of the emergency department. Shock 2014 0.83
144 Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii. Pharmacotherapy 2007 0.83
145 Telavancin for hospital-acquired pneumonia: clinical response and 28-day survival. Antimicrob Agents Chemother 2014 0.83
146 Staphylococcus aureus pneumonia: a "superbug" infection in community and hospital settings. Chest 2005 0.82
147 Effects of an antibiotic cycling program on antibiotic prescribing practices in an intensive care unit. Antimicrob Agents Chemother 2004 0.81
148 Predictors of outcome in 216 subjects with ARDS treated with inhaled epoprostenol. Respir Care 2014 0.81
149 The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Chest 2006 0.80
150 CD4+ lymphocyte adenosine triphosphate determination in sepsis: a cohort study. Crit Care 2010 0.80
151 Health care-associated pneumonia: perception versus reality. Clin Infect Dis 2009 0.80
152 Antibiotics for the critically ill: more than just selecting appropriate initial therapy. Crit Care 2013 0.80
153 Prevention of pneumonia in the hospital setting. Clin Chest Med 2005 0.80
154 Understanding toxic shock syndrome. Intensive Care Med 2015 0.79
155 Preventing ventilator-associated pneumonia: an evidence-based approach of modifiable risk factors. Semin Respir Crit Care Med 2006 0.79
156 Moving towards real-time antimicrobial management of ventilator-associated pneumonia. Clin Infect Dis 2007 0.78
157 Recognition of nosocomial pneumonia in the intensive care unit: still a confusing issue. Respir Care 2011 0.78
158 Vancomycin for methicillin-resistant Staphylococcus aureus pneumonia: the good, the bad, and the ugly. Crit Care Med 2012 0.78
159 Microbiological diagnosis of ventilator-associated pneumonia: using the data to optimize clinical outcomes. Am J Respir Crit Care Med 2006 0.78
160 Probiotics in the intensive care unit: why controversies and confusion abound. Crit Care 2008 0.78
161 Prevention and treatment of methicillin-resistant Staphylococcus aureus colonization in the ICU: a process of care that should be considered mandatory. Crit Care Med 2014 0.78
162 Prevention of VAP: the whole is more than the sum of its parts. Intensive Care Med 2008 0.78
163 Determinants of hospital mortality among patients with sepsis or septic shock receiving appropriate antibiotic treatment. Curr Infect Dis Rep 2013 0.78
164 Quinolones for treatment of nosocomial pneumonia: a meta-analysis. Clin Infect Dis 2005 0.78
165 Probiotics for ventilator-associated pneumonia: the need for a large, multicenter, randomized controlled trial. Chest 2013 0.77
166 Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study. BMJ Open 2013 0.77
167 Management of severe sepsis: integration of multiple pharmacologic interventions. Pharmacotherapy 2003 0.77
168 Treatment of ventilator-associated pneumonia: get it right from the start. Crit Care Med 2003 0.77
169 The quick and the dead: the importance of rapid evaluation of infiltrates in the immunocompromised patient. Chest 2002 0.77
170 Patients hospitalized with pneumonia: determining the need for broad-spectrum antibiotic therapy. Clin Infect Dis 2011 0.77
171 A 50-year-old woman with abdominal pain and respiratory failure 3 months after kidney transplantation. Chest 2008 0.77
172 Treatment of hospital-acquired pneumonia. Lancet Infect Dis 2011 0.77
173 Risk factors for mixed complicated skin and skin structure infections to help tailor appropriate empiric therapy. Surg Infect (Larchmt) 2012 0.76
174 How to stratify patients at risk for resistant bugs in skin and soft tissue infections? Curr Opin Infect Dis 2016 0.76
175 Bacteremia increases the risk of death among patients with soft-tissue infections. Surg Infect (Larchmt) 2010 0.76
176 Optimizing therapy for MRSA pneumonia. Semin Respir Crit Care Med 2007 0.76
177 Update on the appropriate use of meropenem for the treatment of serious bacterial infections. Clin Infect Dis 2008 0.76
178 Institutional perspective on the impact of positive blood cultures on the economic and clinical outcomes of patients with complicated skin and skin structure infections: focus on gram-positive infections. Clin Ther 2011 0.76
179 Healthcare-associated pneumonia: approach to management. Clin Chest Med 2011 0.76
180 Early tracheostomy--has its time arrived? Crit Care Med 2004 0.76
181 Update on ventilator-associated pneumonia. Curr Opin Crit Care 2015 0.76
182 An empirical approach to the treatment of multidrug-resistant ventilator-associated pneumonia. Clin Infect Dis 2003 0.76
183 Antibiotic heterogeneity: should we use it? Crit Care Med 2003 0.76
184 Health care-associated pneumonia. Hosp Pract (1995) 2010 0.76
185 Why is Acinetobacter baumannii a problem for critically ill patients? Intensive Care Med 2015 0.76
186 The road forward in the management of Acinetobacter infections in the ICU. Intensive Care Med 2015 0.75
187 Ventilator-associated pneumonia prevention: we still have a long way to go! Chest 2014 0.75
188 Ventilator-Associated Events: Are We Missing the Forest for the Trees? Crit Care Med 2015 0.75
189 Targeted Fluid Minimization Following Initial Resuscitation in Septic Shock: A Pilot Study. Chest 2015 0.75
190 Ventilator-associated pneumonia: the role of emerging therapies and diagnostics. Chest 2015 0.75
191 A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy? Medicine (Baltimore) 2016 0.75
192 A Quasi-Experimental, Before-After Trial Examining the Impact of an Emergency Department Mechanical Ventilator Protocol on Clinical Outcomes and Lung-Protective Ventilation in Acute Respiratory Distress Syndrome. Crit Care Med 2017 0.75
193 Health-care-associated pneumonia: not just a US phenomenon. Chest 2009 0.75
194 Nonpharmacological prevention of hospital-acquired pneumonia. Semin Respir Crit Care Med 2002 0.75
195 Clinical practice improvement initiatives: don't be satisfied with the early results. Chest 2009 0.75
196 Hospital-acquired pneumonia/ventilator-associated pneumonia prevention: truth or dare! Crit Care Med 2011 0.75
197 Methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization predicts intensive care unit-acquired MRSA infections: true or false? Surg Infect (Larchmt) 2010 0.75
198 Correctly scoring infections: CSI in the ICU. Crit Care Med 2007 0.75
199 Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults: An Observational Cohort Study. Medicine (Baltimore) 2015 0.75
200 Time to get serious about infection prevention in the ICU. Chest 2006 0.75
201 Prevention of ventilator-associated pneumonia: selecting interventions that make a difference. Chest 2002 0.75
202 Ventilator-associated tracheobronchitis and ventilator-associated pneumonia: truth vs myth. Chest 2013 0.75
203 Tracheostomy for respiratory failure: we need more answers. Chest 2004 0.75
204 Open access to infectious disease case-based learning on the Internet. Clin Infect Dis 2008 0.75
205 Should we be debating the importance of timely adequate antimicrobial therapy? Clin Infect Dis 2010 0.75
206 A magic bullet for sepsis: getting back to the basics. Crit Care Med 2010 0.75
207 Preface. Infections in the intensive care unit. Infect Dis Clin North Am 2009 0.75
208 The resuscitation package in sepsis. Curr Infect Dis Rep 2010 0.75
209 Healthcare-associated pneumonia. Semin Respir Crit Care Med 2009 0.75
210 Corticosteroids for Influenza Pneumonia: Hold Off for Now! Crit Care Med 2016 0.75
211 Growth in the incidence of hospitalizations with resistant infections in elderly people in the United States: 2000 to 2006. J Am Geriatr Soc 2008 0.75
212 Determinants of outcome for patients admitted to a long-term ventilator unit. South Med J 2002 0.75
213 A Randomized Trial of Palliative Care Discussions Linked to an Automated Early Warning System Alert. Crit Care Med 2016 0.75
214 Macrolides are associated with a better survival rate in patients hospitalized with community-acquired but not healthcare-associated pneumonia. Surg Infect (Larchmt) 2014 0.75
215 Low Tidal Volume Ventilation for Emergency Department Patients: A Systematic Review and Meta-Analysis on Practice Patterns and Clinical Impact. Crit Care Med 2022 0.75
216 Pulmonary Mechanics and Mortality in Mechanically Ventilated Patients without Acute Respiratory Distress Syndrome: A Cohort Study. Shock 2017 0.75
217 Therapeutic Hyperthermia Is Associated With Improved Survival in Afebrile Critically Ill Patients With Sepsis: A Pilot Randomized Trial. Crit Care Med 2022 0.75
218 Performance of a Modern Glucose Meter in ICU and General Hospital Inpatients: 3 Years of Real-World Paired Meter and Central Laboratory Results. Crit Care Med 2017 0.75